Factors influencing transfusion-associated HLA sensitization in patients bridged to heart transplantation using ventricular assist device.

Our findings indicate that the presence of anti-HLA antibodies pre-VAD was the most significant risk factor for developing additional antibodies post-VAD, suggesting that a subset of patients may be predisposed to alloantibody formation.